Jivan Yewle
About Jivan Yewle
Jivan Yewle serves as the Director of Non-Viral Delivery at Mammoth Biosciences, a position he has held since 2022. With extensive experience in biotechnology, he has previously worked at Poseida Therapeutics and has a strong academic background in chemistry.
Work at Mammoth Biosciences
Jivan Yewle serves as the Director of Non-Viral Delivery at Mammoth Biosciences, a position he has held since 2022. Located in the San Francisco Bay Area, he focuses on advancing non-viral delivery methods for therapeutic applications. His role involves overseeing research and development initiatives aimed at improving the efficacy of gene therapies through innovative delivery systems.
Previous Experience at Poseida Therapeutics
Prior to his current role, Jivan Yewle worked at Poseida Therapeutics, Inc. for a total of four years in various capacities. He began as a Senior Research Scientist in Nanotechnology from 2016 to 2019, where he contributed to the development of advanced therapeutic technologies. He then transitioned to Associate Director of In Vivo Gene Therapy from 2021 to 2022, followed by a role as Senior Research Scientist/NT: Pre-CMC & Analytical Chem Lead from 2019 to 2021, focusing on preclinical development and analytical chemistry.
Educational Background
Jivan Yewle earned his Ph.D. in Chemistry from the University of Kentucky, where he studied from 2005 to 2011. He also holds a Master of Science in Organic Chemistry from Savitribai Phule Pune University, completed between 2000 and 2002. His academic journey included a post-doctoral fellowship at the University of Kentucky College of Pharmacy in 2012, as well as a graduate research assistantship at the University of Kentucky's Department of Chemistry during his doctoral studies.
Achievements in Biotechnology
Jivan Yewle has received notable recognition for his contributions to the biotechnology field. He was awarded the Tibbetts Award in 2016 by the US Small Business Administration for his achievements in biotechnology. Additionally, he received the eAchiever Award in 2015 from the Lexington Venture Club, acknowledging his impact on the biotech industry. His work includes significant advancements in lipid nanoparticle (LNP) technology for gene therapy applications.
Early Career Experience
Jivan Yewle began his career in the pharmaceutical industry with a position as a Research Associate at Glenmark Pharmaceuticals in Mumbai, India, in 2004. He later worked at Dr. Reddy's Laboratories in Hyderabad from 2002 to 2003. His early experiences laid the foundation for his subsequent roles in research and development within the biotechnology sector.